Abstract
The percentage of patients with seronegative spondyloarthritis requiring magnetic resonance imaging to meet the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada guidelines for access to anti-tumor necrosis factor treatment.
Leticia Troppmann, Jacob Karsh and Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada
The Journal of Rheumatology April 2008, 35 (4) 658-661;
In this issue
The percentage of patients with seronegative spondyloarthritis requiring magnetic resonance imaging to meet the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada guidelines for access to anti-tumor necrosis factor treatment.
Leticia Troppmann, Jacob Karsh, Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada
The Journal of Rheumatology Apr 2008, 35 (4) 658-661;
The percentage of patients with seronegative spondyloarthritis requiring magnetic resonance imaging to meet the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada guidelines for access to anti-tumor necrosis factor treatment.
Leticia Troppmann, Jacob Karsh, Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada
The Journal of Rheumatology Apr 2008, 35 (4) 658-661;